Category Archives: Press Release

Pain Management Therapeutics Market to Witness Comprehensive Growth by 2025

The global Pain Management Therapeutics Market is anticipated to rise at a steady pace in the upcoming years on the back of improving healthcare infrastructure, increasing economic stability globally, and increasing penetration of established players in emerging economies that are brimming with growth opportunities. Besides this, growing geriatric population globally, changing lifestyles, and high prevalence of chronic pain are acting in favor of the market’s growth. As per statistics of the National Health Interview Survey, in 2016, almost 20% of the world’s population was reported to be suffering from chronic pain.

Oncology Biosimilars Market to Record an Exponential CAGR by 2025

The global Oncology Biosimilars Market is predicted to benefit immensely with the rising demand for affordable therapies for cancer. This is because cancer is presently the costliest health affair in terms of both diagnosis and treatment. Pharmaceutical companies worldwide are hard-focused on developing biosimilars and generic medicines to combat cancer at all stages and also for the treatment of the disease.

Albumin (as Excipient) Market to Observe Strong Development by 2026

Albumin is a water soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries. However, usage of albumin as multifunctional excipient is increasing due to rise in consumption for applications such as drug formulation, vaccines, drug discovery, culture medium, stabilizing agent, and diagnostics.

Animal Blood Plasma Products and Derivatives Market to Witness Exponential Growth by 2024

Thanks to the technological advancements in blood collection and processing procedure, rising usage of blood plasma products in the human food as well as pet food products industries, and improved supply chain and distribution network across the world, the global market is expanding phenomenally.

The rising demand for these plasma products and derivatives has changed the dynamics of this market, which accounted for US$1.04 bn in 2015. Analysts estimate the opportunity in Animal Blood Plasma Products and Derivatives Market to increase at a CAGR of 7.10% between 2016 and 2024 and reach a value of US$1.92 bn by the end of 2024.

Chlamydia Infection Diagnostics and Therapeutics Market to Expand with Significant CAGR by 2025

The chlamydia infection diagnostics and therapeutics market unveils high potential owing to the rapidly rising patient pool and vast untapped opportunities, especially in developing economies across regions such as Asia Pacific and Latin America. The market expected to exhibit healthy growth in the near future due to the increasing focus on treatment of sexually transmitted diseases globally. There is a need for enhanced techniques of diagnosis of pelvic inflammatory disease and for signs of chlamydial infection that expects women at high threat of tubal damage. Chlamydia trachomatis is the most commonly reported sexually transmitted infection in the world. The rate of reported chlamydia infection diagnoses continues to increase.

Cancer Immunotherapy Market Pegged for Robust Expansion by 2024

The global Cancer Immunotherapy Market is prognosticated to encounter a high rate of development over the coming years, inferable from the rise in number of people suffering from different types of cancers. In 2015, the global cancer immunotherapy market was esteemed at US$37.50 bn. its revenue is anticipated to progress at an extremely solid CAGR of 14.6% inside a conjecture period from 2016 to 2024, the global cancer immunotherapy market is required to achieve US$124.88 bn before the finish of 2024.

Short Bowel Syndrome Market to Surge at a Robust Pace by 2024

Short bowel syndrome (SBS) refers to a disorder that occurs due to the malfunction of the intestine, leading to malabsorption. SBS can be an outcome of various underlying diseases or medical conditions that can cause resection of the intestine. Owing to this the nutrient processing areas in the intestine rendered dysfunction and can lead to dangerous infectious and metabolic disorders. The research report predicts that the global Short Bowel Syndrome Market is expected to rise at a CAGR of 30.4% to reach a valuation of US$2.6 bn by the end of 2024 as compared to be US$312.7 mn in 2016.

Homeopathy Product Market to Reflect Impressive Growth Rate by 2024

The global Homeopathy Product Market has skyrocketed in the past few years, with sales of amounting to billions of dollars in key regions such as Europe, North America, Asia Pacific, and Middle East and Africa. Aversion to allopathic medicines, a constant rise in demand for convenient dosages of a variety of medicines, and an increase in consumer confidence about alternate treatment methodologies are all significantly fueling the market growth.

Furthermore, with the growing amount of disposable income available with individuals, especially from developing regions, the expenditure on the global homeopathy products market has substantially increased over the past few years. This factor is expected to continue benefitting the market due to a lot of homeopathy medicines being reasonably priced but often not being covered by insurance.

Testosterone Replacement Therapy Market Poised to Expand at a Robust Pace by 2024

A wide range of testosterone replacement therapy (TRT) products containing different active ingredients have been made available by a large number of both global and local manufacturers. With various studies estimating the number of men affected by hypogonadism (testosterone deficiency) at 30% worldwide, the demand for TRT is poised to increase gradually in the years ahead. The condition primarily affects men aged between 40 and 79 years, making this demographic a key target segment for market players.

Inhalation and Nasal Spray Generic Drugs Market Foreseen to Grow Exponentially by 2023

The growing number of generic drugs in the market today is primarily attributed to the patent expirations in various medical fields, including inhalers and nasal sprays. The absence of the need for research and development or major marketing strategies allows the average price of generic drugs to have been US$35.22 in 2008, as opposed to the US$137.9 average for branded drugs, according to the NACDS.

The sales of generic inhalers and nasal sprays is expected to increase even further after the release of studies that point to an increase in the number of patients suffering from restrictive and even life-threatening respiratory diseases, such as COPD and asthma. The incredibly high healthcare costs, especially in developed economies, is therefore driving this growing patient pool towards generic drugs.